Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Cribbs

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
Pharmaceutics|October 27, 2022
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 MiceWeijun Ou, Yuu Ohno, Joshua Yang, et al.
Frontiers in Cell and Developmental Biology|August 19, 2021
Insights Into the Mechanisms of Brain Endothelial ErythrophagocytosisJiahong Sun, Prema Vyas, Samar Mann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sitesAnahit Ghochikyan, Mikayel Mkrtichyan, Dmitri Loukinov, et al.
Neurobiology of Disease|May 11, 2010
Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated AbetaVitaly Vasilevko, Viorela Pop, Hyun Jin Kim, et al.
Molecular Neurodegeneration|May 6, 2017
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potencyMichael G Agadjanyan, Karen Zagorski, Irina Petrushina, et al.
European Journal of Immunology|November 25, 2003
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigeneAnahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, et al.
Clinical & Experimental Metastasis|November 6, 2003
Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumorsVitaly Vasilevko, Anahit Ghochikyan, Nadya Sadzikava, et al.
The Journal of Biological Chemistry|June 5, 2007
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomersGrigor Mamikonyan, Mihaela Necula, Mikayel Mkrtichyan, et al.
Journal of Neuroinflammation|January 1, 2022
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathyWeijun Ou, Joshua Yang, Juste Simanauskaite, et al.
Journal of Sickle Cell Disease|March 30, 2026
Cerebral microhemorrhages in a mouse model of sickle cell diseaseYu-Han Hung, Chuo Fang, Donghy Lee, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
Pharmaceutics|October 27, 2022
Efficacy and Safety of a Brain-Penetrant Biologic TNF-α Inhibitor in Aged APP/PS1 MiceWeijun Ou, Yuu Ohno, Joshua Yang, et al.
Frontiers in Cell and Developmental Biology|August 19, 2021
Insights Into the Mechanisms of Brain Endothelial ErythrophagocytosisJiahong Sun, Prema Vyas, Samar Mann, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Elicitation of T cell responses to histologically unrelated tumors by immunization with the novel cancer-testis antigen, brother of the regulator of imprinted sitesAnahit Ghochikyan, Mikayel Mkrtichyan, Dmitri Loukinov, et al.
Neurobiology of Disease|May 11, 2010
Linear and conformation specific antibodies in aged beagles after prolonged vaccination with aggregated AbetaVitaly Vasilevko, Viorela Pop, Hyun Jin Kim, et al.
Molecular Neurodegeneration|May 6, 2017
Humanized monoclonal antibody armanezumab specific to N-terminus of pathological tau: characterization and therapeutic potencyMichael G Agadjanyan, Karen Zagorski, Irina Petrushina, et al.
European Journal of Immunology|November 25, 2003
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigeneAnahit Ghochikyan, Vitaly Vasilevko, Irina Petrushina, et al.
Clinical & Experimental Metastasis|November 6, 2003
Immunization with a vaccine that combines the expression of MUC1 and B7 co-stimulatory molecules prolongs the survival of mice and delays the appearance of mouse mammary tumorsVitaly Vasilevko, Anahit Ghochikyan, Nadya Sadzikava, et al.
The Journal of Biological Chemistry|June 5, 2007
Anti-A beta 1-11 antibody binds to different beta-amyloid species, inhibits fibril formation, and disaggregates preformed fibrils but not the most toxic oligomersGrigor Mamikonyan, Mihaela Necula, Mikayel Mkrtichyan, et al.
Journal of Neuroinflammation|January 1, 2022
Biologic TNF-α inhibitors reduce microgliosis, neuronal loss, and tau phosphorylation in a transgenic mouse model of tauopathyWeijun Ou, Joshua Yang, Juste Simanauskaite, et al.
Journal of Sickle Cell Disease|March 30, 2026
Cerebral microhemorrhages in a mouse model of sickle cell diseaseYu-Han Hung, Chuo Fang, Donghy Lee, et al.
Pageof 13